These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33157291)

  • 21. Staphylococcus aureus bacteremia in an Indian tertiary care hospital: observational study on clinical epidemiology, resistance characteristics, and carriage of the Panton-Valentine leukocidin gene.
    Eshwara VK; Munim F; Tellapragada C; Kamath A; Varma M; Lewis LE; Mukhopadhyay C
    Int J Infect Dis; 2013 Nov; 17(11):e1051-5. PubMed ID: 23891294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safe shortening of antibiotic treatment duration for complicated
    Buis D; van Werkhoven CH; van Agtmael MA; Bax HI; Berrevoets M; de Boer M; Bonten M; Bosmans JE; Branger J; Douiyeb S; Gelinck L; Jong E; Lammers A; Van der Meer J; Oosterheert JJ; Sieswerda E; Soetekouw R; Stalenhoef JE; Van der Vaart TW; Bij de Vaate EA; Verkaik NJ; Van Vonderen M; De Vries PJ; Prins JM; Sigaloff K;
    BMJ Open; 2023 Apr; 13(4):e068295. PubMed ID: 37085305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.
    Lesens O; Methlin C; Hansmann Y; Remy V; Martinot M; Bergin C; Meyer P; Christmann D
    Infect Control Hosp Epidemiol; 2003 Dec; 24(12):890-6. PubMed ID: 14700403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Prospective Cohort Study of Durations of
    Kang CK; Song KH; Kim SE; Kim ES; Park WB; Park KH; Chun SH; Lee S; Cho CR; Kang SJ; Oh MD; Kim YS; Lee SH; Kwak YG; Jang HC; Kim CJ; Kim YK; Bang JH; Kiem S; Kwon KT; Jung Y; Kang YM; Jung SI; Kim HB;
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.
    Falcón R; Mateo E; Oltra R; Giménez E; Albert E; Torres I; Navarro D
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):903-912. PubMed ID: 30729396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guideline compliance and clinical outcomes among patients with Staphylococcus aureus bacteremia with infectious diseases consultation in addition to antimicrobial stewardship-directed review.
    Buehrle K; Pisano J; Han Z; Pettit NN
    Am J Infect Control; 2017 Jul; 45(7):713-716. PubMed ID: 28431847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
    Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
    Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Staphylococcus aureus Bacteremia and Hospital Mortality in Hemodialysis Patients With Bloodstream Infection: A Multicenter Cohort From Japanese Tertiary Care Centers.
    Imaizumi T; Hasegawa T; Nomura A; Sasaki S; Nishiwaki H; Ozeki T; Shimizu H; Minatoguchi S; Yamakawa T; Yazawa M; Uchida D; Kawarazaki H; Miyamoto M; Suzuki T; Koitabashi K; Furusho M; Fujita Y
    Ther Apher Dial; 2017 Aug; 21(4):354-360. PubMed ID: 28498647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of a pharmacist-facilitated, evidence-based bundle initiative on Staphylococcus aureus bacteremia management.
    Kufel WD; Mastro KA; Steele JM; Wang D; Riddell SW; Paolino KM; Thomas SJ
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115535. PubMed ID: 34634714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The management and outcomes of Staphylococcus aureus bacteraemia at a South African referral hospital: A prospective observational study.
    Steinhaus N; Al-Talib M; Ive P; Boyles T; Bamford C; Davies MA; Mendelson M; Wasserman S
    Int J Infect Dis; 2018 Aug; 73():78-84. PubMed ID: 29908251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of Mortality with Staphylococcus aureus Bacteremia in Elderly Adults.
    Bassetti M; Righi E; Del Giacomo P; Sartor A; Ansaldi F; Trucchi C; Alicino C; Trecarichi EM; Spanu T; Paganino C; Tumbarello M; Carnelutti A
    J Am Geriatr Soc; 2018 Jul; 66(7):1284-1289. PubMed ID: 29664994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time trends in Staphylococcus aureus bacteremia, 1988-2010, in a tertiary center with high methicillin resistance rates.
    Yahav D; Shaked H; Goldberg E; Yassin S; Eliakim-Raz N; Paul M; Bishara J; Leibovici L
    Infection; 2017 Feb; 45(1):51-57. PubMed ID: 27411532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of delayed appropriate antimicrobial therapy on children with Staphylococcus aureus blood infection.
    Guo Z; Xu X; Zhang G; Wang X; Tian X; Li Y; Li Q; Chen D; Luo Z
    Eur J Pediatr; 2024 Sep; 183(9):3785-3796. PubMed ID: 38874791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis.
    Ma H; Cheng J; Peng L; Gao Y; Zhang G; Luo Z
    PLoS One; 2020; 15(3):e0230383. PubMed ID: 32191760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study.
    Kaasch AJ; Rieg S; Kuetscher J; Brodt HR; Widmann T; Herrmann M; Meyer C; Welte T; Kern P; Haars U; Reuter S; Hübner I; Strauss R; Sinha B; Brunkhorst FM; Hellmich M; Fätkenheuer G; Kern WV; Seifert H;
    Infection; 2013 Oct; 41(5):979-85. PubMed ID: 23539143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial.
    Kaasch AJ; López-Cortés LE; Rodríguez-Baño J; Cisneros JM; Dolores Navarro M; Fätkenheuer G; Jung N; Rieg S; Lepeule R; Coutte L; Bernard L; Lemaignen A; Kösters K; MacKenzie CR; Soriano A; Hagel S; Fantin B; Lafaurie M; Talarmin JP; Dinh A; Guimard T; Boutoille D; Welte T; Reuter S; Kluytmans J; Martin ML; Forestier E; Stocker H; Vitrat V; Tattevin P; Rommerskirchen A; Noret M; Adams A; Kern WV; Hellmich M; Seifert H;
    Lancet Infect Dis; 2024 May; 24(5):523-534. PubMed ID: 38244557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of infectious disease consultation on patients with Staphylococcus aureus bacteremia at a Japanese tertiary hospital: A retrospective observational study.
    Suzuki J; Sasahara T; Minami K; Morisawa Y; Yamada T
    J Infect Chemother; 2020 Aug; 26(8):780-784. PubMed ID: 32423701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia.
    Fätkenheuer G; Preuss M; Salzberger B; Schmeisser N; Cornely OA; Wisplinghoff H; Seifert H
    Eur J Clin Microbiol Infect Dis; 2004 Mar; 23(3):157-62. PubMed ID: 14986158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.
    Nagao M; Yamamoto M; Matsumura Y; Yokota I; Takakura S; Teramukai S; Ichiyama S
    Infection; 2017 Feb; 45(1):83-91. PubMed ID: 27709434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long versus short course anti-microbial therapy of uncomplicated Staphylococcus aureus bacteraemia: a systematic review.
    Schnizer M; Schellong P; Rose N; Fleischmann-Struzek C; Hagel S; Abbas M; Payne B; Evans RN; Pletz MW; Weis S
    Clin Microbiol Infect; 2024 Oct; 30(10):1254-1260. PubMed ID: 38823452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.